FDA Inspection
UBI Pharma, Inc.UBI Pharma, Inc. – FDA Inspection, Jun 20, 2019
Record Details
This FDA Inspection record concerns UBI Pharma, Inc., with an inspection on June 20, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · df85d9ee-ae80-49ae-b430-d7efd7d8a70d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1095285
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of UBI Pharma, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2025 | Not classified | Office of Inspections and Investigations | |
| June 6, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 21, 2018 | Not classified | Office of Inspections and Investigations | |
| May 4, 2018 | Not classified | Office of Inspections and Investigations | |
| July 18, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for UBI Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.